Molecular imaging with SPECT as a tool for drug development
- 8 October 2010
- journal article
- review article
- Published by Elsevier
- Vol. 63 (7) , 547-554
- https://doi.org/10.1016/j.addr.2010.09.015
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Lung Vascular Targeting Using Antibody to Aminopeptidase P: CT-SPECT Imaging, Biodistribution and Pharmacokinetic AnalysisJournal of Vascular Research, 2010
- Evaluation of a Novel Arg-Gly-Asp-Conjugated α-Melanocyte Stimulating Hormone Hybrid Peptide for Potential Melanoma TherapyBioconjugate Chemistry, 2009
- Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumabAnnals of Oncology, 2008
- Design and performance of a multi-pinhole collimation device for small animal imaging with clinical SPECT and SPECT–CT scannersPhysics in Medicine & Biology, 2008
- Designing Phase 0 Cancer Clinical TrialsClinical Cancer Research, 2008
- Phase 0 Clinical Trials in Cancer Drug Development: From FDA Guidance to Clinical PracticeMolecular Interventions, 2007
- CommentaryBritish Journal of Clinical Pharmacology, 2006
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Pharmacokinetic ImagingClinical Pharmacokinetics, 2002
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001